For: | Leung C, Herath CB, Jia Z, Andrikopoulos S, Brown BE, Davies MJ, Rivera LR, Furness JB, Forbes JM, Angus PW. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22(35): 8026-8040 [PMID: 27672297 DOI: 10.3748/wjg.v22.i35.8026] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i35/8026.htm |
Number | Citing Articles |
1 |
Fahimeh Agh, Farzad Shidfar. Dietary Interventions in Liver Disease. 2019; : 213 doi: 10.1016/B978-0-12-814466-4.00018-5
|
2 |
Kathleen Priken, Gladys Tapia, Cynthia Cadagan, Nicolás Quezada, Javiera Torres, Amanda D'Espessailles, Paulina Pettinelli. Higher hepatic advanced glycation end products and liver damage markers are associated with nonalcoholic steatohepatitis. Nutrition Research 2022; 104: 71 doi: 10.1016/j.nutres.2022.04.005
|
3 |
David Ríos-Covian, Maria Carmen Collado, Carina Venter, Carlos Gómez-Gallego, Clara G. de los Reyes-Gavilán, Sonia González. Editorial: Xenobiotics from diet and health: impact on microbiome. Frontiers in Nutrition 2024; 10 doi: 10.3389/fnut.2023.1342142
|
4 |
Lindsay L. Peterson, Jennifer A. Ligibel. Dietary and serum advanced glycation end-products and clinical outcomes in breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(1): 188995 doi: 10.1016/j.bbcan.2023.188995
|
5 |
Matina Kouvari, Thomas Tsiampalis, Rena I. Kosti, Nenad Naumovski, Christina Chrysohoou, John Skoumas, Christos S. Pitsavos, Demosthenes B. Panagiotakos, Christos S. Mantzoros. Quality of plant-based diets is associated with liver steatosis, which predicts type 2 diabetes incidence ten years later: Results from the ATTICA prospective epidemiological study. Clinical Nutrition 2022; 41(10): 2094 doi: 10.1016/j.clnu.2022.07.026
|
6 |
Hadeer M. Abouelezz, George S.G. Shehatou, Abdelhadi M. Shebl, Hatem A. Salem. A standardized pomegranate fruit extract ameliorates thioacetamide-induced liver fibrosis in rats via AGE-RAGE-ROS signaling. Heliyon 2023; 9(3): e14256 doi: 10.1016/j.heliyon.2023.e14256
|
7 |
Fangfei Xie, Jing Zhao, Di Liu, Zhongxiao Wan, Kangyun Sun, Yun Wang. Associations of dietary advanced glycation end products with liver steatosis via vibration controlled transient elastography in the United States: a nationwide cross-sectional study. European Journal of Nutrition 2024; 63(1): 173 doi: 10.1007/s00394-023-03253-2
|
8 |
Donald B. Jump, Kelli A. Lytle, Christopher M. Depner, Sasmita Tripathy. Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease. Pharmacology & Therapeutics 2018; 181: 108 doi: 10.1016/j.pharmthera.2017.07.007
|
9 |
Kamyar Asadipooya, Edilfavia Mae Uy. Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature. Journal of the Endocrine Society 2019; 3(10): 1799 doi: 10.1210/js.2019-00160
|
10 |
Yuzhu Xu, Menghe Huang, Yingting Chen, Lintao Yu, Meiran Wu, Shiyue Kang, Qiuyu Lin, Qiaoxuan Zhang, Liqiao Han, Haibiao Lin, Peifeng Ke, Wenjin Fu, Qizhi Tang, Jun Yan, Xianzhang Huang. Development of simultaneous quantitation method for 20 free advanced glycation end products using UPLC–MS/MS and clinical application in kidney injury. Journal of Pharmaceutical and Biomedical Analysis 2024; 242: 116035 doi: 10.1016/j.jpba.2024.116035
|
11 |
Yunting Xie, Yafang Ma, Linlin Cai, Shuai Jiang, Chunbao Li. Reconsidering Meat Intake and Human Health: A Review of Current Research. Molecular Nutrition & Food Research 2022; 66(9) doi: 10.1002/mnfr.202101066
|
12 |
Marci Laudenslager, Mariana Lazo, Dan Wang, Elizabeth Selvin, Po-Hung Chen, James S. Pankow, Jeanne M. Clark. Association between the soluble receptor for advanced glycation end products (sRAGE) and NAFLD in participants in the Atherosclerosis Risk in Communities Study. Digestive and Liver Disease 2021; 53(7): 873 doi: 10.1016/j.dld.2021.02.005
|
13 |
Linzehao Li, Qinghe Song, Xiandang Zhang, Yan Yan, Xiaolei Wang. Allicin Alleviates Diabetes Mellitus by Inhibiting the Formation of Advanced Glycation End Products. Molecules 2022; 27(24): 8793 doi: 10.3390/molecules27248793
|
14 |
Qiaozhi Zhang, Yanbo Wang, Linglin Fu. Dietary advanced glycation end‐products: Perspectives linking food processing with health implications. Comprehensive Reviews in Food Science and Food Safety 2020; 19(5): 2559 doi: 10.1111/1541-4337.12593
|
15 |
Mitchell Bijnen, Nicky Beelen, Suzan Wetzels, José van de Gaar, Maria Vroomen, Erwin Wijnands, Jean L. Scheijen, Marjo P. H van de Waarenburg, Marion J. Gijbels, Jack P. Cleutjens, Erik A. L. Biessen, Coen D. A. Stehouwer, Casper G. Schalkwijk, Kristiaan Wouters. RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr−/− mice. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33661-y
|
16 |
F. Taghavi, Ali A. Moosavi-Movahedi. Plant and Human Health, Volume 2. 2019; : 1 doi: 10.1007/978-3-030-03344-6_1
|
17 |
Evelyn Nunes Goulart da Silva Pereira, Beatriz Peres de Araujo, Karine Lino Rodrigues, Raquel Rangel Silvares, Carolina Souza Machado Martins, Edgar Eduardo Ilaquita Flores, Caroline Fernandes-Santos, Anissa Daliry. Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE Stress. Nutrients 2022; 14(3): 716 doi: 10.3390/nu14030716
|
18 |
Andrea Deledda, Giuseppe Annunziata, Gian Carlo Tenore, Vanessa Palmas, Aldo Manzin, Fernanda Velluzzi. Diet-Derived Antioxidants and Their Role in Inflammation, Obesity and Gut Microbiota Modulation. Antioxidants 2021; 10(5): 708 doi: 10.3390/antiox10050708
|
19 |
Fahimeh Mohammadghasemi, Masumeh Abbasi, Kamran Rudkhaneei, Monireh Aghajany-Nasab. Beneficial effect of apple vinegar on reproductive parameters in male rat model of nonalcoholic fatty liver disease. Andrologia 2018; 50(8): e13065 doi: 10.1111/and.13065
|
20 |
Kamyar Asadipooya, Kamran B. Lankarani, Rishi Raj, Mohammadreza Kalantarhormozi. RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease. International Journal of Endocrinology 2019; 2019: 1 doi: 10.1155/2019/2151302
|
21 |
Wiramon Rungratanawanich, Ying Qu, Xin Wang, Musthafa Mohamed Essa, Byoung-Joon Song. Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury. Experimental & Molecular Medicine 2021; 53(2): 168 doi: 10.1038/s12276-021-00561-7
|
22 |
Grigorios Christidis, Frederic Küppers, Senem Ceren Karatayli, Ersin Karatayli, Susanne N. Weber, Frank Lammert, Marcin Krawczyk. Skin advanced glycation end-products as indicators of the metabolic profile in diabetes mellitus: correlations with glycemic control, liver phenotypes and metabolic biomarkers. BMC Endocrine Disorders 2024; 24(1) doi: 10.1186/s12902-024-01558-9
|
23 |
Chenping Du, Rani O. Whiddett, Irina Buckle, Chen Chen, Josephine M. Forbes, Amelia K. Fotheringham. Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development. Cells 2022; 11(21): 3503 doi: 10.3390/cells11213503
|
24 |
Evelyn Nunes Goulart da Silva Pereira, Raquel Rangel Silvares, Edgar Eduardo Ilaquita Flores, Karine Lino Rodrigues, Isalira Peroba Ramos, Igor José da Silva, Marcelo Pelajo Machado, Rosiane Aparecida Miranda, Carmen Cabanelas Pazos-Moura, Cassiano F. Gonçalves-de-Albuquerque, Hugo Caire de Castro Faria-Neto, Eduardo Tibiriça, Anissa Daliry, Jordi Gracia-Sancho. Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease. PLOS ONE 2017; 12(6): e0179654 doi: 10.1371/journal.pone.0179654
|
25 |
José Ignacio Martínez-Montoro, Isabel Cornejo-Pareja, Ana María Gómez-Pérez, Francisco J. Tinahones. Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease. Nutrients 2021; 13(11): 4077 doi: 10.3390/nu13114077
|
26 |
Mitra Kazemi Jahromi, Asal Neshatbini Tehrani, Farshad Teymoori, Ghazal Daftari, Hamid Ahmadirad, Niloufar Saber, Ammar Salehi-Sahlabadi, Hossein Farhadnejad, Parvin Mirmiran. Dietary advanced glycation end products are associated with an increased risk of non-alcoholic fatty liver disease in Iranian adults. BMC Endocrine Disorders 2023; 23(1) doi: 10.1186/s12902-023-01365-8
|
27 |
Laura Toma, Gabriela M. Sanda, Loredan S. Niculescu, Mariana Deleanu, Camelia S. Stancu, Anca V. Sima. Caffeic acid attenuates the inflammatory stress induced by glycated LDL in human endothelial cells by mechanisms involving inhibition of AGE‐receptor, oxidative, and endoplasmic reticulum stress. BioFactors 2017; 43(5): 685 doi: 10.1002/biof.1373
|
28 |
Rai Ajit K. Srivastava. Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity. Journal of Diabetes & Metabolic Disorders 2018; 17(2): 381 doi: 10.1007/s40200-018-0378-y
|
29 |
Liyun Xu, Wen Liu, Fuxiang Bai, Yong Xu, Xiaohong Liang, Chunhong Ma, Lifen Gao. Hepatic Macrophage as a Key Player in Fatty Liver Disease. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.708978
|
30 |
Maciej Krasnodębski, Marcin Morawski, Jan Borkowski, Karolina Grąt, Jan Stypułkowski, Michał Skalski, Andriy Zhylko, Marek Krawczyk, Michał Grąt. Skin Autofluorescence Measurement as Initial Assessment of Hepatic Parenchyma Quality in Patients Undergoing Liver Resection. Journal of Clinical Medicine 2022; 11(18): 5341 doi: 10.3390/jcm11185341
|
31 |
Yan Zhang, Lu Dong, Jinhui Zhang, Jiaqi Shi, Yaya Wang, Shuo Wang. Adverse Effects of Thermal Food Processing on the Structural, Nutritional, and Biological Properties of Proteins. Annual Review of Food Science and Technology 2021; 12(1): 259 doi: 10.1146/annurev-food-062320-012215
|
32 |
Dinali H. Fernando, Josephine M. Forbes, Peter W. Angus, Chandana B. Herath. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products. International Journal of Molecular Sciences 2019; 20(20): 5037 doi: 10.3390/ijms20205037
|
33 |
Fahimeh Shams, Monireh Aghajani-nasab, Mahsa Ramezanpour, Razieh Habibipour Fatideh, Fahimeh Mohammadghasemi. Effect of apple vinegar on folliculogenesis and ovarian kisspeptin in a high-fat diet-induced nonalcoholic fatty liver disease in rat. BMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01205-1
|
34 |
Hye-Bin Lee, Ju Hyeong Choi, Donghwan Kim, Kwang-Won Lee, Sang Keun Ha, Sang-Hoon Lee, Ho-Young Park. Dietary Nε-(carboxymethyl)lysine is a trigger of non-alcoholic fatty liver disease under high-fat consumption. Food and Chemical Toxicology 2023; 180: 114010 doi: 10.1016/j.fct.2023.114010
|
35 |
Kamil Litwinowicz, Ewa Waszczuk, Aleksandra Kuzan, Agnieszka Bronowicka-Szydełko, Kinga Gostomska-Pampuch, Piotr Naporowski, Andrzej Gamian. Alcoholic Liver Disease Is Associated with Elevated Plasma Levels of Novel Advanced Glycation End-Products: A Preliminary Study. Nutrients 2022; 14(24): 5266 doi: 10.3390/nu14245266
|
36 |
Jian Wan, Xiangsong Wu, Hanbei Chen, Xinyi Xia, Xi Song, Song Chen, Xinyuan Lu, Jie Jin, Qing Su, Dongsheng Cai, Bin Liu, Bo Li. Aging‐induced aberrant RAGE/PPARα axis promotes hepatic steatosis via dysfunctional mitochondrial β oxidation. Aging Cell 2020; 19(10) doi: 10.1111/acel.13238
|
37 |
Hui Han, Romain Desert, Sukanta Das, Zhuolun Song, Dipti Athavale, Xiaodong Ge, Natalia Nieto. Danger signals in liver injury and restoration of homeostasis. Journal of Hepatology 2020; 73(4): 933 doi: 10.1016/j.jhep.2020.04.033
|
38 |
Lijun Wang, Hongli Zhang, Tuo Xu, Jing Zhang, Yuanyuan Liu, Yue Qu. Effects of cheerleading practice on advanced glycation end products, areal bone mineral density, and physical fitness in female adolescents. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.954672
|
39 |
Louis H. S. Lau, Sunny H. Wong. Obesity, Fatty Liver and Liver Cancer. Advances in Experimental Medicine and Biology 2018; 1061: 111 doi: 10.1007/978-981-10-8684-7_9
|
40 |
Evelyn Nunes Goulart da Silva Pereira, Raquel Rangel Silvares, Edgar Eduardo Ilaquita Flores, Karine Lino Rodrigues, Anissa Daliry. Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease. Microcirculation 2020; 27(3) doi: 10.1111/micc.12603
|
41 |
Jessica Lambertz, Thorsten Berger, Tak W. Mak, Josef van Helden, Ralf Weiskirchen. Lipocalin-2 in Fructose-Induced Fatty Liver Disease. Frontiers in Physiology 2017; 8 doi: 10.3389/fphys.2017.00964
|
42 |
Ho-Young Park, Hye-Bin Lee, So-Young Lee, Mi-Jin Oh, Sang Keun Ha, Eunju Do, Hyun Hee L. Lee, Jinyoung Hur, Kwang-Won Lee, Mi-Hyun Nam, Myoung Gyu Park, Yoonsook Kim. Lactococcus lactis KF140 Reduces Dietary Absorption of Nε - (Carboxymethyl)lysine in Rats and Humans via β-Galactosidase Activity. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.916262
|
43 |
Natalia Vallianou, Gerasimos Socrates Christodoulatos, Irene Karampela, Dimitrios Tsilingiris, Faidon Magkos, Theodora Stratigou, Dimitris Kounatidis, Maria Dalamaga. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Biomolecules 2021; 12(1): 56 doi: 10.3390/biom12010056
|
44 |
Kamil Litwinowicz, Ewa Waszczuk, Andrzej Gamian. Advanced Glycation End-Products in Common Non-Infectious Liver Diseases: Systematic Review and Meta-Analysis. Nutrients 2021; 13(10): 3370 doi: 10.3390/nu13103370
|
45 |
Geoffrey C. Farrell, Fahrettin Haczeyni, Shivakumar Chitturi. Obesity, Fatty Liver and Liver Cancer. Advances in Experimental Medicine and Biology 2018; 1061: 19 doi: 10.1007/978-981-10-8684-7_3
|
46 |
Jiao Wang, Honghong Liu, Guijiao Xie, Wei Cai, Jixiong Xu. Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10872
|
47 |
A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE. PLOS ONE 2019; 14(5): e0216736 doi: 10.1371/journal.pone.0216736
|
48 |
Kristiaan Wouters, Alessia S. Cento, Katrien H. Gaens, Margee Teunissen, Jean L. J. M. Scheijen, Federica Barutta, Fausto Chiazza, Debora Collotta, Manuela Aragno, Gabriella Gruden, Massimo Collino, Casper G. Schalkwijk, Raffaella Mastrocola. Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systems. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-96859-7
|
49 |
Oren Tirosh, Michal Verman, Dana Ivancovsky-Wajcman, Laura Sol Grinshpan, Naomi Fliss-Isakov, Muriel Webb, Oren Shibolet, Revital Kariv, Shira Zelber-Sagi. Differential effects of low or high-fat dairy and fat derived from dairy products on MASLD. JHEP Reports 2024; : 101194 doi: 10.1016/j.jhepr.2024.101194
|
50 |
Rohini Mehta, Gladys Shaw, Peter Masschelin, Sean Felix, Munkzhul Otgonsuren, Ancha Baranova, Zachary Goodman, Zobair Younossi, Barry I. Hudson. Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH). PLOS ONE 2018; 13(6): e0199294 doi: 10.1371/journal.pone.0199294
|
51 |
Haoqu Tan, Jinfang Hu, Wei Zuo, Yun Huang, Jian Cui, Fei Gong, Wei Bai. Loss of RAGE prevents chronic intermittent hypoxia-induced nonalcoholic fatty liver disease via blockade of NF-кB pathway. Gene Therapy 2023; 30(3-4): 278 doi: 10.1038/s41434-022-00351-4
|
52 |
Nan Zhong, Yingjie Yao, Yongzheng Ma, Xinyue Meng, Alphonse Sowanou, Junrui Pei. Effects of Fluoride on Oxidative Stress Markers of Lipid, Gene, and Protein in Rats. Biological Trace Element Research 2021; 199(6): 2238 doi: 10.1007/s12011-020-02336-z
|
53 |
Jin-Ah Lee, Min Ji Gu, Yu Ra Lee, Yoonsook Kim, Inwook Choi, Donghwan Kim, Sang Keun Ha. Lindera obtusiloba Blume Alleviates Non-Alcoholic Fatty Liver Disease Promoted by Nε-(carboxymethyl)lysine. Nutrients 2024; 16(14): 2330 doi: 10.3390/nu16142330
|
54 |
Govigerel Bayarsaikhan, Delger Bayarsaikhan, Jaewon Lee, Bonghee Lee. Targeting Scavenger Receptors in Inflammatory Disorders and Oxidative Stress. Antioxidants 2022; 11(5): 936 doi: 10.3390/antiox11050936
|
55 |
Y Xu, H Guo. Role of Advanced Glycation End Products in the Progression of Diabetes Mellitus. Global Journal of Obesity, Diabetes and Metabolic Syndrome 2017; 4(1): 024 doi: 10.17352/2455-8583.000019
|
56 |
Yang Yang, Jing Yu, Jiayao Huo, Yaping Yan. Sesamin Attenuates Obesity-Associated Nonalcoholic Steatohepatitis in High-Fat and High-Fructose Diet-Fed Mice. Journal of Medicinal Food 2023; 26(3): 176 doi: 10.1089/jmf.2022.K.0091
|
57 |
John B. Furness, Jeremy J. Cottrell. Signalling from the gut lumen. Animal Production Science 2017; 57(11): 2175 doi: 10.1071/AN17276
|
58 |
Yuqi Gao, Rui Hua, Kaiqiang Hu, Zhao Wang. Carbohydrates deteriorate fatty liver by activating the inflammatory response. Nutrition Research Reviews 2022; 35(2): 252 doi: 10.1017/S0954422421000202
|